Abcam Company

Abcam helps researches with breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.


Investors

Technology: Research Kit or Other Laboratory Practice Supplies
Headquarters: Cambridge, United Kingdom
Total Funding: $37.7M
Last Funding Type: Series B
Number Of Exists: 1001-5000
Founded Date: 1998
Investors Number: 6
Industry: Omics-based, Systemic
Estimated Revenue: $50M to $100M